Identical or similar brand names used in different countries for medications with different active ingredients: a descriptive analysis
| Autor: | Lubna Merchant, Randall Lutter, Sherry Chang |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Pharmacies
Active ingredient Brand names Wrong drug Descriptive statistics United States Food and Drug Administration business.industry Health Policy technology industry and agriculture Advertising United States Article Food and drug administration Pharmaceutical Preparations Humans Medication Errors Name confusion Medicine Medical prescription medicine.symptom Confusion business health care economics and organizations |
| Zdroj: | BMJ Qual Saf |
| ISSN: | 2044-5423 2044-5415 |
| DOI: | 10.1136/bmjqs-2019-010316 |
| Popis: | ObjectiveTo identify US drug brand (proprietary) names that are identical or similar to drug brand names used in other countries containing different active ingredients and name confusion medication errors associated with these drugs.MethodsWe compared a list of brand names approved by the US Food and Drug Administration from 2006 through 2018 with a list of brand names from other countries generated by Uppsala Monitoring Centre using the WHODrug Dictionary. We evaluated drug name pairs that were identical or highly similar and had different active ingredients and searched for name confusion medication errors with these drugs.ResultsA total of 27 US brand names were found to be identical to 38 drug brand names in other countries with different active ingredients. A total of 74 US drug brand names were highly similar to 93 brand names in other countries for drugs containing different active ingredients. We identified name confusion medication errors for one similar name pair.ConclusionsUS drug brand names that are identical to or highly similar to brand names in other countries may cause confusion that can lead to medication errors such as wrong drug errors and wrong drug information being consulted. Manufacturers should consider this risk prior to submitting proposed brand names to regulatory authorities. Regulatory authorities may consider incorporating this check in their brand name reviews and work with manufacturers to eliminate the use of the same or similar brand names for products with different ingredients. Consumers filling prescriptions at foreign pharmacies should also be aware of potential name confusion. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|